Michael Tsoukas
Division of Endocrinology and Metabolism - McGill University Health Center · Clinique Medicale Hygea · McGill University Health Centre/Research Institute of the McGill University Health Centre
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Tsoukas as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:43 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT06894784 · A Clinical Trial to Evaluate The Effects of Semaglutide and Empagliflozin Combined to Automated Insulin Delivery on Diabetes Control in Adults Living With Type 1 DiabetesMcGill University Health Centre/Research Institute of the McGill University Health Centre · recruiting · Diabetes Type 1 · principal investigator
- Ph1NCT06753994 · Continuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 InhibitorsMcGill University · completed · Diabetes, Type1diabetes, T1D · principal investigator
- Ph2/Ph3NCT06046417 · A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 DiabetesMcGill University Health Centre/Research Institute of the McGill University Health Centre · unknown · type1diabetes, Diabetes Mellitus, Type 1 · principal investigator
- Ph2NCT06021158 · A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 DiabetesMcGill University Health Centre/Research Institute of the McGill University Health Centre · unknown · Diabetes Mellitus, Type 1, Type 1 Diabetes · principal investigator
- N/ANCT05514080 · A Study to Evaluate Eli Lilly's Insulin Dosing Algorithm to Control Glycemia in Insulin-treated Adults With Type 2 DiabetesMcGill University · completed · Diabetes Mellitus, Type 2 · principal investigator
- N/ANCT05199714 · A Fully-closed Loop, Pramlintide and Insulin, Artificial Pancreas Clinical Trial for Adults With Type 1 DiabetesMcGill University Health Centre/Research Institute of the McGill University Health Centre · completed · Type 1 Diabetes · principal investigator
- N/ANCT05041621 · A Learning Algorithm for MDI Individuals With Type 1 Diabetes to Adjust Recommendations for High Fat Meals and Exercise ManagementMcGill University · completed · Type 1 Diabetes · principal investigator
- Ph1NCT04972175 · Safety and Efficacy of BC LisPramMichael Tsoukas · unknown · Type1 Diabetes Mellitus · principal investigator
- Ph1NCT04450563 · Low Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin SystemMcGill University · completed · Type 1 Diabetes · principal investigator
- N/ANCT04123054 · A Novel mHealth Application Guided by an Optimization Algorithm for T1D Sensor-Augmented Insulin Injection UsersMcGill University · completed · Diabetes Mellitus, Diabetes Mellitus, Type 1 · principal investigator
- Ph2NCT03800875 · Insulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate CountingMcGill University · completed · Diabetes Mellitus, Type 1 · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Alleviating carbohydrate counting in adults with type 1 diabetes with weekly Semaglutide injections added to an automated insulin delivery with Lyumjev R01DK135765 · NIDDK · MCGILL UNIVERSITY HEALTH CTR RES INST · fiscal years 2023 to 2025 · $180,712 awarded in 2025Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:43 UTC. The ranking covers the 200 most relevant of 26 PubMed records, and a shared surname and initials can bring in a namesake. All 26 on PubMed
- 244 citationsRCR 9.7
- A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial.Diabetes Care · 202096 citationsRCR 5.3
- 90 citationsRCR 3.3
- A Randomized Trial of Automated Insulin Delivery in Type 2 Diabetes.N Engl J Med · 202570 citationsRCR 19.3
- 60 citationsRCR 14.3
- A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial.Lancet Digit Health · 202141 citationsRCR 2.6
- Accuracy of FreeStyle Libre in Adults with Type 1 Diabetes: The Effect of Sensor Age.Diabetes Technol Ther · 202037 citationsRCR 2.4
- Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.Diabetes Obes Metab · 202135 citationsRCR 2.3
- Empagliflozin add-on therapy to closed-loop insulin delivery in type 1 diabetes: a 2 × 2 factorial randomized crossover trial.Nat Med · 202235 citationsRCR 2.8
- 24 citationsRCR 1.6